Similar Risk Patterns after Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines

Julia C. Gage, William C. Hunt, Mark Schiffman, Hormuzd A. Katki, Li A. Cheung, Orrin Myers, Jack Cuzick, Nicolas Wentzensen, Walter Kinney, Philip E. Castle, Cosette M. Wheeler

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

OBJECTIVE: To compare the risks of histologic high-grade cervical intraepithelial neoplasia (CIN) or worse after different cervical cancer screening test results between two of the largest U.S. clinical practice research data sets. METHODS: The New Mexico Human Papillomavirus (HPV) Pap Registry is a statewide registry representing a diverse population experiencing varied clinical practice delivery. Kaiser Permanente Northern California is a large integrated health care delivery system practicing routine HPV cotesting since 2003. In this retrospective cohort study, a logistic-Weibull survival model was used to estimate and compare the cumulative 3- and 5-year risks of histologic CIN 3 or worse among women aged 21-64 years screened in 2007-2011 in the New Mexico HPV Pap Registry and 2003-2013 in Kaiser Permanente Northern California. Results were stratified by age and baseline screening result: negative cytology, atypical squamous cells of undetermined significance (ASC-US) (with or without HPV triage), low-grade squamous intraepithelial lesion, and high-grade squamous intraepithelial lesion. RESULTS: There were 453,618 women in the New Mexico HPV Pap Registry and 1,307,528 women at Kaiser Permanente Northern California. The 5-year CIN 3 or worse risks were similar within screening results across populations: cytology negative (0.52% and 0.30%, respectively, P<.001), HPV-negative and ASC-US (0.72% and 0.49%, respectively, P.5), ASC-US (3.4% and 3.4%, respectively, P.8), HPV-positive and ASC-US (7.7% and 7.1%, respectively, P.3), low-grade squamous intraepithelial lesion (6.5% and 5.4%, respectively, P.009), and high-grade squamous intraepithelial lesion (53.1% and 50.4%, respectively, P.2). Cervical intraepithelial neoplasia grade 2 or worse risks and 3-year risks had similar trends across populations. Age-stratified analyses showed more variability, especially among women aged younger than 30 years, but patterns of risk stratification were comparable. CONCLUSION: Current U.S. cervical screening and management recommendations are based on comparative risks of histologic high-grade CIN after screening test results. The similar results from these two large cohorts from different real-life clinical practice settings support risk-based management thresholds across U.S. clinical populations and practice settings.

Original languageEnglish (US)
Pages (from-to)1248-1257
Number of pages10
JournalObstetrics and gynecology
Volume128
Issue number6
DOIs
StatePublished - Dec 1 2016

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Similar Risk Patterns after Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines'. Together they form a unique fingerprint.

  • Cite this

    Gage, J. C., Hunt, W. C., Schiffman, M., Katki, H. A., Cheung, L. A., Myers, O., Cuzick, J., Wentzensen, N., Kinney, W., Castle, P. E., & Wheeler, C. M. (2016). Similar Risk Patterns after Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstetrics and gynecology, 128(6), 1248-1257. https://doi.org/10.1097/AOG.0000000000001721